First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

NCT00251186 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Colorectal Cancer

Interventions

DRUG: Capecitabine and Cetuximab

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]
[object Object]